Cargando…
Transport of L-Arginine Related Cardiovascular Risk Markers
L-arginine and its derivatives, asymmetric and symmetric dimethylarginine (ADMA and SDMA) and L-homoarginine, have emerged as cardiovascular biomarkers linked to cardiovascular outcomes and various metabolic and functional pathways such as NO-mediated endothelial function. Cellular uptake and efflux...
Autores principales: | Banjarnahor, Sofna, Rodionov, Roman N., König, Jörg, Maas, Renke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764698/ https://www.ncbi.nlm.nih.gov/pubmed/33302555 http://dx.doi.org/10.3390/jcm9123975 |
Ejemplares similares
-
Screening of commonly prescribed drugs for effects on the CAT1-mediated transport of l-arginine and arginine derivatives
por: Banjarnahor, Sofna, et al.
Publicado: (2022) -
L-Arginine and Cardioactive Arginine Derivatives as Substrates and Inhibitors of Human and Mouse NaCT/Nact
por: Surrer, Daniela B., et al.
Publicado: (2022) -
Vectorial transport of the arginine derivatives asymmetric dimethylarginine (ADMA) and l-homoarginine by OATP4C1 and P-glycoprotein studied in double-transfected MDCK cells
por: Taghikhani, Emir, et al.
Publicado: (2020) -
The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginine
por: Taghikhani, Emir, et al.
Publicado: (2019) -
The prognostic biomarker L-homoarginine is a substrate of the cationic amino acid transporters CAT1, CAT2A and CAT2B
por: Chafai, Anja, et al.
Publicado: (2017)